Modification of Histidine (B10) Is the Causative Agent for a Superactive Form of Insulin
- 18 January 2002
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 290 (2) , 775-777
- https://doi.org/10.1006/bbrc.2001.6253
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Insulins today and beyondThe Lancet, 2001
- The Long Acting Human Insulin Analog HOE 901: Characteristics of Insulin Signalling in Comparison to Asp(B10) and Regular InsulinHormone and Metabolic Research, 1998
- Engineering stability of the insulin monomer fold with application to the structure-activity relationshipBiochemistry, 1993
- Recombinant-DNA-derived insulin analogues as potentially useful therapeutic agentsTrends in Biotechnology, 1993
- A superactive insulin: [B10-aspartic acid]insulin(human).Proceedings of the National Academy of Sciences, 1987
- An insulin derivative with biological activity greater than that of native insulinJournal of Cellular Physiology, 1976
- Characterization of super-active insulin, prolactin and placental lactogenBiochemical and Biophysical Research Communications, 1975
- Insulin-Unresponsive Tissues Respond to Superactive Insulin-Like MaterialScience, 1975
- Structure of a soluble super-active insulin is revealed by the nature of the complex between cyanogen-bromide-activated sepharose and amines.Proceedings of the National Academy of Sciences, 1975
- A Soluble Super-Active Form of InsulinProceedings of the National Academy of Sciences, 1974